|
1
|
World Health Organization: Report of the
commission on ending childhood obesity. Implementation plan:
Executive summary. Geneva: World Health Organization, 2017.
|
|
2
|
Al Dhaifallah A, Mwanri L and Aljoudi A:
Childhood obesity in Saudi Arabia: Opportunities and challenge.
Saudi J Obesity. 3:2–7. 2015.
|
|
3
|
Cui X, You L, Zhu L, Wang X, Zhou Y, Li Y,
Wen J, Xia Y, Wang X, Ji C and Guo X: Change in circulating
microRNA profile of obese children indicates future risk of adult
diabetes. Metab Clin Exp. 78:95–105. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mohany KM, Al Rugaie O, Al-wutayd O,
Al-Nafeesah A and Saleem TH: Association between circulating
microRNAs 486, 146b and 15b and serum betatrophin levels in obese;
type 2 diabetic and non-diabetic children. BMC Endocr Disord.
20(145)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB
and Schulze MB: Transition from metabolic healthy to unhealthy
phenotypes and association with cardiovascular disease risk across
BMI categories in 90 257 women (the Nurses' Health Study): 30 Year
follow-up from a prospective cohort study. Lancet Diabetes
Endocrinol. 6:714–724. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Blüher M: Metabolically healthy obesity.
Endocr Rev. 41(bnaa004)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Caleyachetty R, Thomas GN, Toulis KA,
Mohammed N, Gokhale KM, Balachandran K and Nirantharakumar K:
Metabolically healthy obese and incident cardiovascular disease
events among 3.5 million men and women. J Am Coll Cardiol.
70:1429–1437. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ellulu MS, Patimah I, Khaza'ai H, Rahmat A
and Abed Y: Obesity and inflammation: The linking mechanism and the
complications. Arch Med Sci. 13:851–863. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Iacomino G and Siani A: Role of microRNAs
in obesity and obesity-related diseases. Genes Nutr.
12(23)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Marques-Rocha JL, Samblas M, Milagro FI,
Bressan J, Martínez JA and Marti A: Noncoding RNAs, cytokines, and
inflammation-related diseases. FASEB J. 29:3595–3611.
2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yang WM, Jeong HJ, Park SW and Lee W:
Obesity-induced miR-15b is linked causally to the development of
insulin resistance through the repression of the insulin receptor
in hepatocytes. Mol Nutr Food Res. 59:2303–2314. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhong H, Ma M, Liang T and Guo L: Role of
MicroRNAs in obesity-induced metabolic disorder and immune
response. J Immunol Res. 2018(2835761)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sugimoto MA, Vago JP, Teixeira MM and
Sousa LP: Annexin A1 and the resolution of inflammation: Modulation
of neutrophil recruitment, apoptosis, and clearance. J Immunol Res.
2016(8239258)2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pietrani NT, Ferreira CN, Rodrigues KF,
Perucci LO, Carneiro FS, Bosco AA, Oliveira MC, Pereira SS,
Teixeira AL, Alvarez-Leite JI, et al: Proresolving protein Annexin
A1: The role in type 2 diabetes mellitus and obesity. Biomed
Pharmacother. 103:482–489. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Aguilera CM, Gomez-Llorente C, Tofe I,
Gil-Campos M, Cañete R and Gil Á: Genome-wide expression in
visceral adipose tissue from obese prepubertal children. Int J Mol
Sci. 16:7723–7737. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kosicka A, Cunliffe AD, Mackenzie R,
Zariwala MG, Perretti M, Flower RJ and Renshaw D: Attenuation of
plasma Annexin A1 in human obesity. FASEB J. 27:368–378.
2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Abbasi A, Corpeleijn E, Postmus D,
Gansevoort RT, de Jong PE, Gans RO, Struck J, Hillege HL, Stolk RP,
Navis G and Bakker SJ: Plasma procalcitonin is associated with
obesity, insulin resistance, and the metabolic syndrome. J Clin
Endocrinol Metab. 95:E26–E31. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
El Kassas GM, Shehata MA, El Wakeel MA,
Amer AF, Elzaree FA, Darwish MK and Amer MF: Role of procalcitonin
as an inflammatory marker in a sample of Egyptian children with
simple obesity. Open Access Maced J Med Sci. 6:1349–1353.
2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Khaodhiar L, Ling PR, Blackburn GL and
Bistrian BR: Serum levels of interleukin-6 and C-reactive protein
correlate with body mass index across the broad range of obesity.
JPEN J Parenter Enteral Nutr. 28:410–415. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Takumansang R, Warouw SM and Lestari H:
Interleukin-6 and insulin resistance in obese adolescents. Paediatr
Indones. 53:268–272. 2013.
|
|
21
|
El-Mikkawy DM, EL-Sadek MA, EL-Badawy MA
and Samaha D: Circulating level of interleukin-6 in relation to
body mass indices and lipid profile in Egyptian adults with
overweight and obesity. Egypt Rheumatol Rehabil. 47(7)2020.
|
|
22
|
Zimmet P, Alberti KG, Kaufman F, Tajima N,
Silink M, Arslanian S, Wong G, Bennett P, Shaw J and Caprio S: IDF
Consensus Group. The metabolic syndrome in children and
adolescents-an IDF consensus report. Pediatr Diabetes. 8:299–306.
2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ivo D'Urso P, Fernando D'Urso O, Damiano
Gianfreda C, Mezzolla V, Storelli C and Marsigliante S: miR-15b and
miR-21 as circulating biomarkers for diagnosis of glioma. Curr
Genomics. 16:304–311. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Garvey WT, Mechanick JI, Brett EM, Garber
AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pessah-Pollack R and
Plodkowski R: Reviewers of the AACE/ACE Obesity Clinical Practice
Guidelines. American association of clinical endocrinologists and
American college of endocrinology comprehensive clinical practice
guidelines for medical care of patients with obesity. Endocr Pract.
22 (Suppl 3):S1–S203. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Neeland IJ, Ross R, Després JP, Matsuzawa
Y, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B,
et al: Visceral and ectopic fat, atherosclerosis, and
cardiometabolic disease: A position statement. Lancet Diabetes
Endocrinol. 7:715–725. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Vukovic R, Dos Santos TJ, Ybarra M and
Atar M: Children with metabolically healthy obesity: A review.
Front Endocrinol (Lausanne). 10(865)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li Y and Shi X: MicroRNAs in the
regulation of TLR and RIG-I pathways. Cell Mol Immunol. 10:65–71.
2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sajid S, Renshaw D, Burke B and Mee C:
Investigating the role of Annexin A1 in adipogenesis and its
ability to dampen obesity associated inflammation. Endocr Abstr.
50(335)2017.
|
|
31
|
Becker KL, Snider R and Nylen ES:
Procalcitonin in sepsis and systemic inflammation: A harmful
biomarker and a therapeutic target. Br J pharmacol. 159:253–264.
2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Briel M, Schuetz P, Mueller B, Young J,
Schild U, Nusbaumer C, Périat P, Bucher HC and Christ-Crain M:
Procalcitonin-guided antibiotic use vs a standard approach for
acute respiratory tract infections in primary care. Arch Intern
Med. 168:2000–2008. 2008.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mehanic S and Baljic R: The importance of
serum procalcitonin in diagnosis and treatment of serious bacterial
infections and sepsis. Mater Sociomed. 25:277–281. 2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Linscheid P, Seboek D, Schaer DJ, Zulewski
H, Keller U and Müller B: Expression and secretion of procalcitonin
and calcitonin gene-related peptide by adherent monocytes and by
macrophage-activated adipocytes. Crit Care Med. 32:1715–1721.
2004.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Van Gaal LF, Mertens IL and De Block CE:
Mechanisms linking obesity with cardiovascular disease. Nature.
444:875–880. 2006.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ghanem AI and Khalid M: Association of
serum procalcitonin (PCT) and high-sensitivity C-reactive protein
(hs-CRP) levels with insulin resistance and obesity in type 2
Egyptian diabetic patients. Med J Cairo Univ. 84:1165–1171.
2016.
|
|
37
|
Boursier G, Avignon A, Kuster N, Boegner
C, Leprieur E, Picandet M, Bargnoux AS, Badiou S, Dupuy AM, Cristol
JP and Sultan A: Procalcitonin, an independent marker of abdominal
fat accumulation in obese patients. Clin Lab. 62:435–441.
2016.PubMed/NCBI View Article : Google Scholar
|
